Skip to content

Efficacy of intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: a randomized, double-blind, placebo-controlled clinical trial

Efficacy of intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: a randomized, double-blind, placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017273
Enrollment
Unknown
Registered
2018-07-20
Start date
2018-08-05
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

airway foreign body

Interventions

D:intranasal dexmedetomidinen
C:intranasal normal saline

Sponsors

West China Second Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 4 Years

Inclusion criteria

Inclusion criteria: Children aged 6-48 months undergoing foreign body removal under fiberoptic bronchoscopy.

Exclusion criteria

Exclusion criteria: Children with cogential disease, children with a family history of malignant hyperthermia, with coagulation dysfunction,with respiratory distress syndrome, allergy to anesthesia drugs and children's legal guardian refused to sign informed consent will be excluded.

Design outcomes

Primary

MeasureTime frame
the incidence of hypoxemia;the incidence of body movement during operation;the incidence of laryngospasm;the incidence of tracheal spasm;

Secondary

MeasureTime frame
separation score;Agitation Score;Tolerance of the anesthetic mask;ET CO2;HR;SPO2;

Countries

China

Contacts

Public ContactLan Wu

West China Second Hospital, Sichuan University

bbyanmei@yeah.net+86 028-85503753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026